Py. Perera et al., LIPOPOLYSACCHARIDE AND ITS ANALOG ANTAGONISTS DISPLAY DIFFERENTIAL SERUM FACTOR DEPENDENCIES FOR INDUCTION OF CYTOKINE GENES IN MURINE MACROPHAGES, Infection and immunity, 66(6), 1998, pp. 2562-2569
Monocytes/macrophages play a central role in mediating the effects of
lipopolysaccharide (LPS) derived from gram-negative bacteria by the pr
oduction of proinflammatory mediators. Recently, it was shown that the
expression of cytokine genes for tumor necrosis factor alpha (TNF-alp
ha), interleukin-1 beta (IL-1 beta), and interferon-inducible protein-
10 (IP-10) by murine macrophages in response to low concentrations of
LPS is entirely CD14 dependent. In this report, we show that murine ma
crophages respond to low concentrations of LPS (less than or equal to
2 ng/ml) in the complete absence of serum, leading to the induction of
TNF-alpha and IL-1 beta genes. In contrast to the TNF-or and IL-1 bet
a genes, the IP-10 gene is poorly induced in the absence of serum. The
addition of recombinant human soluble CD14 (rsCD14) had very little e
ffect on the levels of serum-free, LPS-induced TNF-alpha, IL-1 beta, a
nd IP-10 genes. In contrast, the addition of recombinant human LPS-bin
ding protein (rLBP) had opposing effects on the LPS-induced TNF-alpha
or IL-1 beta and IP-10 genes, rLBP inhibited LPS-induced TNF-alpha and
IL-1 beta genes, while it reconstituted IP-10 gene expression to leve
ls induced in the presence of serum. These results provide further evi
dence that the induction of TNF-alpha or IL-1 beta genes occurs via a
pathway that is distinct from one that leads to the induction of the I
P-10 gene and that the pathways diverge at the level of the initial in
teraction between LPS and cellular CD14. Additionally, the results pre
sented here indicate that LPS structural analog antagonists Rhodobacte
r sphaeroides diphosphoryl lipid A and SDZ 880.431 are able to inhibit
LPS-induced TNF-alpha and IL-1 beta in the absence of serum, while a
synthetic analog of Rhodobacter capsulatus lipid A (B 975) requires bo
th rsCD14 and rLBP to function as an inhibitor.